Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect - Wikidata - wikimedia - TriplyDB

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

http://www.wikidata.org/entity/Q34535147

about

Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis.Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis.The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.Immunological landscape of consensus clusters in colorectal cancer.Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients.Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass.Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas.Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer Bioinformatics Analysis Reveals Most Prominent Gene Candidates to Distinguish Colorectal Adenoma from Adenocarcinoma

P2860

Q28082510-50B0400F-3B77-4507-91CC-B9D45217B7D1 Q35751045-6553081B-A059-42F3-8F58-A3CC075C1B50 Q35813626-54F1EC56-8632-4E68-B39B-001888B892D1 Q36027048-64232E37-E352-48A9-99EC-E6118C39B838 Q38857627-871ED52D-C21B-496B-AB64-0E5FE6D52812 Q38893314-F58026B0-6ECB-4350-8B21-C9AD6044C876 Q39037160-727BD5A5-0FDB-42EE-BB9E-73EF82685F64 Q47148210-6C6033A5-A03F-4F37-ACD4-4400FF16C7E6 Q48017354-194DB400-96AB-49D5-B52C-B8F12DC62C7A Q50770445-4A3DA596-B5EB-431A-B726-4BF1F0DA30A5 Q52871138-5FB1EB38-F6FE-47CC-986F-E773A336DC13 Q54160838-9F00DCEF-492C-4BED-A802-04ABB09B3EE7 Q58773660-6328FA93-1C08-4F6B-A367-344565E14B3F Q58798715-DD4911E6-8726-44F4-9226-7B46FD396B45

P2860

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

http://www.wikidata.org/entity/Q34535147

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@ast

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@en

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@nl

type

label

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@ast

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@en

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@nl

prefLabel

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@ast

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@en

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@nl

P1433

Q34535147-F3220BCD-468D-45A0-BCA5-680FF58DCCFE

P1476

Q34535147-D08C30CF-F6AD-48D5-97DD-DD9B477EE891

P2093

Q34535147-12ABFB05-9F21-4D50-932C-E7CAA124FF72

Q34535147-3B80364B-9CDB-4D5E-805E-69D751CAAFB5

Q34535147-57FD6F3B-C2F3-4B02-8D05-3A6CEFBBA4C7

Q34535147-5F06B172-24A2-4DA8-A1AA-DDE9D435B22D

Q34535147-75D9F927-38F1-4575-8D70-674FF40BF780

Q34535147-88175B51-24AE-4C16-9F60-5C5CCFF16A8B

Q34535147-94C6870E-44B2-4510-94E3-48B0D482F5CF

Q34535147-9C488B33-9DF9-4075-A798-30577659396C

Q34535147-A336493C-169F-4BAD-8850-0B028186EDEC

Q34535147-E03BFA10-9CB6-4604-A204-33D4C8EEFD9E

P2860

Q34535147-09445F74-9B31-4F2F-94C3-64CC43F684B2

Q34535147-0DB68D5A-43E9-4AA1-9954-F6C352195FA9

Q34535147-2C3512D9-2153-4FC7-BF2B-4E93E90F91F9

Q34535147-3044AF78-D7A9-4E2C-939F-98DB023E6382

Q34535147-35BE946C-6ACD-4117-A9BF-44493B1CF26B

Q34535147-394AC5F7-7DB9-4876-8F2C-6055C7A87E5F

Q34535147-3DBE7415-72C0-438C-8674-DC11C54682F9

Q34535147-3E71EAE7-6397-4348-AF63-F4065872D6DB

Q34535147-41C7B790-1390-41EB-9381-DA92A70871E9

Q34535147-41F7BF58-7DCA-4F1F-AD0B-D865160C5921

P304

Q34535147-859A8ABB-71C0-49C2-B9F8-347B0CA9FFFB

P31

Q34535147-3133A3B4-BB63-4CD7-BD4B-0DC93AC3619A

P356

Q34535147-811F84BB-AD4C-43C2-9BA3-DE4EB6C4D193

P407

Q34535147-A99FAAFC-CD97-4487-87D6-EEBCD8C1ACEC

P433

Q34535147-60AD9B7F-33FD-4861-93DD-90C5CE1288B7

P478

Q34535147-8A0620C0-42C8-40E6-9B13-21B07E83A372

P577

Q34535147-10FDB445-FD5C-4C5A-AFB6-EBC3AB5078FF

P5875

Q34535147-93CB4860-B0A4-420A-B2F6-7855846ECBFE

P698

Q34535147-CD398353-9C41-4FF3-9827-65227B4B413C

P932

Q34535147-740FB1CA-1EC7-4B4D-A7E9-5782A4404B35

P356

JOURNAL.PONE.0106143

P1433

P1476

Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect

@en

P2093

Alexandra Kalmár

http://www.w3.org/2001/XMLSchema#string

Arpád V Patai

http://www.w3.org/2001/XMLSchema#string

Barnabás Wichmann

http://www.w3.org/2001/XMLSchema#string

Bálint Péterfia

http://www.w3.org/2001/XMLSchema#string

Béla Molnár

http://www.w3.org/2001/XMLSchema#string

Emese Mihály

http://www.w3.org/2001/XMLSchema#string

Ferenc Sipos

http://www.w3.org/2001/XMLSchema#string

Györgyi Műzes

http://www.w3.org/2001/XMLSchema#string

Gábor Valcz

http://www.w3.org/2001/XMLSchema#string

István Fűri

http://www.w3.org/2001/XMLSchema#string

P2860

Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling

Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer

Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas

Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Soluble frizzled-related protein 1 is estrogen inducible in bone marrow stromal cells and suppresses the earliest events in lymphopoiesis

Field defects in progression to gastrointestinal tract cancers

Wnt/β-catenin signaling and disease

Wnt3a binds to several sFRPs in the nanomolar range

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

P304

e106143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0106143

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268795590

http://www.w3.org/2001/XMLSchema#string

P698

25405986

http://www.w3.org/2001/XMLSchema#string

P932

4236006

http://www.w3.org/2001/XMLSchema#string